Anthropic’s IPO Filing Walks Back Bold Biology Claims as Company Prepares to Go Public
Anthropic’s Oct. 27, 2026 IPO filing tempers CEO Dario Amodei’s promises to cure most diseases within 5–10 years, acknowledging the company lacks hands-on drug-discovery experience. It calls Claude’s “Crispr-like” enzyme only a possible future tool.